Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
The Journal of Antibiotics|October 1, 1976
Antibacterial activity of efrotomycinB M Frost, M E Valiant, B Weissberger, et al.The Journal of Antibiotics|June 1, 1979
Antibacterial activity of heneicomycinB M Frost, M E Valiant, E L DulaneyChemotherapy|January 1, 1976
In vitro and in vivo activity of 3-(1-methyl 1-5-nitro-2-imidazolylmethylideneamino)-2-oxazolidinone against PasteurellaB M Frost, M E Valiant, E L DulaneyChemotherapy|January 1, 1984
An experimental model for evaluation of antifungal agents in a Trichophyton mentagrophytes infection of guinea pigsM E Valiant, B M FrostThe Journal of Antibiotics|August 1, 1988
L-656,575 (OCP-9-176): a novel oxacephem. In vitro activity against aerobic and anaerobic clinical bacterial isolatesB Weissberger, G K Abruzzo, R A Fromtling, et al.Antimicrobial Agents and Chemotherapy|March 1, 1988
Antibacterial activities of fluorovinyl- and chlorovinylglycine and several derived dipeptidesA A Patchett, D Taub, B Weissberger, et al.Applied Microbiology|December 1, 1971
Two compounds inhibitory to penicillinase-producing cells of Staphylococcus aureusE L DulaneyThe Journal of Antibiotics|March 1, 1977
In vitro development of resistance to fosfomycinE L Dulaney, C L RubyThe Journal of Antibiotics|May 1, 1989
L-658,310, a new injectable cephalosporin. II. In vitro and in vivo interactions between L-658,310 and various aminoglycosides or ciprofloxacin versus clinical isolates of Pseudomonas aeruginosaM E Valiant, E C Gilfillan, H H Gadebusch, et al.Chemotherapy|January 1, 1977
Effect of fosfomycin on the fecal microflora of manD Hendlin, E Celozzi, B Weissberger, et al.Pageof 3